📰 Granted News
Page 58 - Granted News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Granted. Real-time updates on events, politics, business and more.
April 28, 2023
2023 Performance Share Plan Award - Ms J Brown, CFO Designate 2023 Performance Share Plan Award On 27 April 2023, the Company granted conditional share awards to... | April 28, 2023
April 28, 2023
Investigation. back to you. >> erin mclaughlin with that reporting, thank you. just ahead, a game changer for weight loss? the new diabetes drug that had life changing results for some people dealing with obesity. >> even though im a smaller person now, i feel that im more physical. permission to dig in? granted. breyers carbsmart is so rich, so creamy,
April 28, 2023
RELEASE DISCLOSURE OF TRADING IN OWN SHARES FROM APRIL 24 TO APRIL 28, 2023 In accordance with the authorization granted by the... | April 28, 2023
April 28, 2023
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted inducement awards on April 28,... | April 28, 2023
April 27, 2023
Cobalt Blue is a mining and mineral processing company focussed on the development of the Broken Hill Cobalt Project in New South Wales, Australia. The portfolio of three granted tenements in a total area of 49 km2 containing large-tonnage... - Veroeffentlicht am 27.04.2023
April 27, 2023
By Chris Wack Editas Medicine Inc. said Thursday that the U.S. Food and Drug Administration granted its Orphan Drug Designation to EDIT-301, an investigational gene-editing medicine, for the... | April 27, 2023
April 27, 2023
-Total Revenues of $520 Million in 1Q23, Including Net Product Sales of $469 Million- -PADCEV® Granted FDA Accelerated Approval in Combination with KEYTRUDA® as First-Line Treatment for... | April 27, 2023
April 27, 2023
BOCA RATON, Fla., April 27, 2023 -- NewtekOne, Inc. , today announced that its wholly owned bank subsidiary, Newtek Bank N.A., was granted Preferred Lenders Program status by the Small Business... | April 27, 2023
April 25, 2023
NEW YORK and LONDON, April 25, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases
April 25, 2023
FDA granted accelerated approval of QALSODY based on a reduction of neurofilament, a marker of neurodegeneration1Superoxide dismutase 1 -amyotrophic lateral sclerosis is a devastating, uniformly... | April 25, 2023